300 related articles for article (PubMed ID: 23826135)
1. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
4. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
6. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
7. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
8. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis].
Wu XB; Wang RY; Gong SR; Zhu J; Zhu S
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958
[No Abstract] [Full Text] [Related]
9. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
[TBL] [Abstract][Full Text] [Related]
10. LAMC2 is a predictive marker for the malignant progression of leukoplakia.
Nguyen CT; Okamura T; Morita KI; Yamaguchi S; Harada H; Miki Y; Izumo T; Kayamori K; Yamaguchi A; Sakamoto K
J Oral Pathol Med; 2017 Mar; 46(3):223-231. PubMed ID: 27529842
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
14. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
[TBL] [Abstract][Full Text] [Related]
17. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
